Bronchiectasis with chronic obstructive pulmonary disease: Association or a further phenotype?

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 8, 2013, Pages 786-788

  Stockley, Robert A ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EDITORIAL; EMPHYSEMA; HUMAN; MEDICAL TERMINOLOGY; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION;

BRONCHIECTASIS; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84876883255     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201302-0203ED     Document Type: Editorial

References (19)

1. Senior RM, Tegner H, Kuhn C, Ohlsson K, Starcher BC, Pierce JA. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis 1977;116:469-475. (Pubitemid 8181304)
2. Kuhn C, Yu SY, Chraplyvy M, Linder HE, Senior RM. The induction of emphysema with elastase. II: changes in connective tissue. Lab Invest 1976;34:372-380.
3. Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, Fallahnejad M, Weinbaum G. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986;78:482-493. (Pubitemid 16074086)
4. Gompertz S, Hill AT, Bayley DL, Stockley RA. Effect of expectoration on inflammation in induced sputum in α-1-antitrypsin deficiency. Respir Med 2006;100:1094-1099.
5. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852. (Pubitemid 35178607)
6. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001;17:1112-1119. (Pubitemid 32717466)
7. White AJ, O'Brien C, Hill SL, Stockley RA. Exacerbations of COPD diagnosed in primary care: Changes in spirometry and relationship to symptoms. COPD 2005;2:419-425. (Pubitemid 43879440)
8. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996;153:1802-1811. (Pubitemid 26187903)
9. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204. (Pubitemid 17009877)
10. Seemungal TA, Wilkinson TM, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;178:1139-1147.
11. Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, Roche N. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009;135:975-982.
12. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-764. (Pubitemid 34984972)
13. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288-295.
14. Smith IE, Jurriaans E, Diederich S, Ali N, Shneerson JM, Flower CD. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax 1996;51:914-918. (Pubitemid 26289031)
15. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55:635-642. (Pubitemid 30468217)
16. Parr DG, Guest PJ, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in α1-antitrypsin deficiency. Am J Respir Crit Care Med 2007;176:1215-1221. (Pubitemid 350256475)
17. Martínez-García M-A, de la Rosa Carrillo D, Soler-Cataluña J-J, Donat-Sanz Y, Catalán Serra P, Agramunt Lerma M, Ballestín J, Valero Sánchez I, Selma Ferrer MJ. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:823-831.
18. Boutou AK, Shrikrishna D, Tanner RJ, Smith C, Kelly JL, Ward SP, Polkey MI, Hopkinson NS. Lung function indices for predicting mortality in chronic obstructive pulmonary disease. Eur Respir J (In press)
19. Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2012;186:657-665.